The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zynerba Pharmaceuticals, Inc(NASDAQ:ZYNE) 
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe...
Website: http://www.zynerba.com
Founded: 2007
Full Time Employees: 28
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Zynerba Pharmaceuticals Op Cashflow Per Share ttm
Zynerba Pharmaceuticals Free Cashflow Per Share ttm
Zynerba Pharmaceuticals Cash Per Share ttm
Zynerba Pharmaceuticals (GAAP) P/E ratio ttm
Zynerba Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.